Tuyskanova M S, Zhugunissov K D, Ozaslan M, Myrzakhmetova B S, Kutumbetov L B
Research Institute for Biological Safety Problems.
Al-Farabi Kazakh National University.
Vopr Virusol. 2023 Dec 26;68(6):513-525. doi: 10.36233/0507-4088-202.
At the beginning of December 2019, humanity has faced a new problem caused by coronavirus. In Hubei province of central China, epidemic events associated with severe primary viral pneumonia in humans began to develop. The isolated etiological agent was identified as a representative of family. The global pandemic associated with the new coronavirus infection, acute respiratory syndrome type 2 (Severe acute respiratory syndrome 2, SARS-CoV-2), has become a challenge for humanity.
In our work, we assessed the replicative ability and pathogenesis of the SARS-CoV-2 virus in hamsters.
Syrian hamsters (=16) randomly divided into two groups were used in experiment. The first group was infected intranasally with the SARS-CoV-2 virus, strain SARS-CoV-2/human/KAZ/KZ_Almaty/2020 deposited in GenBank under number MZ379258.1. The second group remained as a control group. Clinical manifestations of the disease in hamsters were observed within 14 days. Samples were collected on days 3, 5, 7, 9, 12, and 14 postinfection. The obtained samples were tested for viral isolation in cell culture, histological examination and analysis of viral RNA by RT-PCR.
SARS-CoV-2 virus isolates showed efficient replication in the lungs of hamsters, causing pathological lung lesions in animals infected intranasally. Clinical manifestations of the disease in hamsters infected with this virus were characterized by a decrease in temperature and body weight, wetness and ruffled fur, and frequent stroking of the nasal planum. High virus titers were observed following the virus isolation in cell cultures from nasal, oral swabs and lungs of animals infected intranasally. Pathological autopsy demonstrated pathological changes in the lungs. Moreover, transmission by airborne droplets has been established when a healthy hamster was kept together with animals infected using the intranasal method.
In conclusion, our study showed that the Syrian hamster model is a useful tool for studying the SARS-CoV-2 pathogenesis, as well as testing vaccine candidates against acute respiratory syndrome type 2.
2019年12月初,人类面临了由冠状病毒引发的新问题。在中国中部的湖北省,与人类严重原发性病毒性肺炎相关的疫情开始出现。分离出的病原体被确定为一个病毒家族的代表。与新型冠状病毒感染(严重急性呼吸综合征2型,SARS-CoV-2)相关的全球大流行已成为人类面临的一项挑战。
在我们的研究中,我们评估了SARS-CoV-2病毒在仓鼠体内的复制能力和致病机制。
实验使用了16只叙利亚仓鼠,随机分为两组。第一组通过鼻内接种GenBank中登录号为MZ379258.1的SARS-CoV-2病毒毒株SARS-CoV-2/human/KAZ/KZ_Almaty/2020进行感染。第二组作为对照组。在14天内观察仓鼠的疾病临床表现。在感染后的第3、5、7、9、12和14天采集样本。对获得的样本进行细胞培养病毒分离、组织学检查以及通过逆转录聚合酶链反应(RT-PCR)分析病毒RNA。
SARS-CoV-2病毒分离株在仓鼠肺部显示出高效复制,在经鼻内感染的动物中引起肺部病理损伤。感染该病毒的仓鼠的疾病临床表现为体温和体重下降、毛发湿润且蓬乱以及频繁抓挠鼻平面。从经鼻内感染动物的鼻、口拭子和肺部进行细胞培养病毒分离后观察到高病毒滴度。病理尸检显示肺部有病理变化。此外,当一只健康仓鼠与经鼻内感染的动物饲养在一起时,已证实存在空气飞沫传播。
总之,我们的研究表明叙利亚仓鼠模型是研究SARS-CoV-2致病机制以及测试针对严重急性呼吸综合征2型候选疫苗的有用工具。